These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6158980

  • 1. Distribution of glycoproteins containing fucose in normal and psoriatic keratinocytes.
    Mann PR, Williams RH, Gray GM.
    Br J Dermatol; 1980 Jun; 102(6):649-57. PubMed ID: 6158980
    [Abstract] [Full Text] [Related]

  • 2. Studies on the plasma membrane of normal and psoriatic keratinocytes. 3. Uptake of labelled sugars and their incorporation into glycoconjugates.
    Roelfzema H, Bergers M, Van Erp PE, Gommans JM, Mier PD.
    Br J Dermatol; 1981 Jun; 104(6):635-40. PubMed ID: 6166310
    [Abstract] [Full Text] [Related]

  • 3. Surface glycoproteins of cultured human keratinocytes from normal and uninvolved psoriatic epidermis.
    Kariniemi AL, Lehto VP, Virtanen I.
    Br J Dermatol; 1983 Nov; 109(5):531-7. PubMed ID: 6196046
    [Abstract] [Full Text] [Related]

  • 4. Studies on the plasma membrane of normal and psoriatic keratinocytes. 6. Cell surface and shed glycoproteins.
    Roelfzema H, van Erp PE.
    J Invest Dermatol; 1983 Jan; 80(1):24-6. PubMed ID: 6184420
    [Abstract] [Full Text] [Related]

  • 5. Studies on the plasma membrane of normal and psoriatic keratinocytes. 4. Characterization of glycoconjugates.
    Roelfzema H, Bergers M, van Erp PE, Gommans JM, Mier PD.
    Br J Dermatol; 1981 Nov; 105(5):509-16. PubMed ID: 6170303
    [Abstract] [Full Text] [Related]

  • 6. Studies on the plasma membrane of normal and psoriatic keratinocytes. 5. Lectin binding.
    Gommans JM, van den Hurk JJ, Bergers M, van Erp P, Mier PD, Roelfzema H.
    Br J Dermatol; 1982 Mar; 106(3):317-22. PubMed ID: 6175329
    [Abstract] [Full Text] [Related]

  • 7. Glycoprotein composition of psoriatic epidermis in relation to growth control.
    Roelfzema H, van Erp PE.
    J Invest Dermatol; 1983 Jan; 80(1):20-3. PubMed ID: 6848606
    [Abstract] [Full Text] [Related]

  • 8. Two keratins MW 50,000 and 56,000 are synthesized by psoriatic epidermis.
    McGuire J, Osber M, Lightfoot L.
    Br J Dermatol; 1984 Jul; 111 Suppl 27():27-37. PubMed ID: 6204677
    [Abstract] [Full Text] [Related]

  • 9. Expression of the L-fucose moiety on epidermal keratinocytes in psoriasis induced by the Koebner phenomenon: a sequential study.
    Heng MC, Heng SY, Allen SG.
    Br J Dermatol; 1992 Jun; 126(6):575-81. PubMed ID: 1610708
    [Abstract] [Full Text] [Related]

  • 10. RNA, DNA, and cell surface characteristics of lesional and nonlesional psoriatic skin.
    Staiano-Coico L, Gottlieb AB, Barazani L, Carter DM.
    J Invest Dermatol; 1987 May; 88(5):646-51. PubMed ID: 2437219
    [Abstract] [Full Text] [Related]

  • 11. Isolation of plasma membranes from keratinocytes: a newly developed method allows the sensitive detection of the membrane antigen pattern in normal and psoriatic skin.
    Licht A, Bauer C, Stadler R.
    Exp Dermatol; 1992 Aug; 1(2):67-75. PubMed ID: 1365307
    [Abstract] [Full Text] [Related]

  • 12. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.
    Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN.
    Br J Dermatol; 1995 Oct; 133(4):501-11. PubMed ID: 7577575
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased DNA synthesis of uninvolved psoriatic epidermis is maintained in vitro.
    Kragballe K, Desjarlais L, Marcelo CL.
    Br J Dermatol; 1985 Mar; 112(3):263-70. PubMed ID: 2579668
    [Abstract] [Full Text] [Related]

  • 15. Surface ultrastructure of cultures of affected psoriatic keratinocytes, unaffected psoriatic keratinocytes and normal keratinocytes.
    Nielsen EH, Elberg JJ, Rønne M, Jahn H, Bierring F.
    Acta Pathol Microbiol Immunol Scand A; 1987 Nov; 95(6):303-8. PubMed ID: 2446464
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T, Nishioka K.
    Skin Pharmacol Appl Skin Physiol; 2003 Nov; 16(1):50-8. PubMed ID: 12566829
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2.
    Fleischmajer R, Kuroda K, Hazan R, Gordon RE, Lebwohl MG, Sapadin AN, Unda F, Iehara N, Yamada Y.
    J Invest Dermatol; 2000 Nov; 115(5):771-7. PubMed ID: 11069613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.